Centene Co. (NYSE:CNC) EVP Sells $647,920.00 in Stock

Centene Co. (NYSE:CNCGet Rating) EVP Shannon Bagley sold 8,000 shares of the firm’s stock in a transaction dated Friday, April 29th. The stock was sold at an average price of $80.99, for a total value of $647,920.00. Following the transaction, the executive vice president now directly owns 128,353 shares in the company, valued at approximately $10,395,309.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of Centene stock opened at $80.34 on Wednesday. The company has a fifty day moving average price of $84.83 and a 200 day moving average price of $80.00. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.68. Centene Co. has a twelve month low of $59.67 and a twelve month high of $89.92. The stock has a market cap of $46.99 billion, a price-to-earnings ratio of 31.88, a price-to-earnings-growth ratio of 1.04 and a beta of 0.52.

Centene (NYSE:CNCGet Rating) last announced its quarterly earnings results on Tuesday, April 26th. The company reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.68 by $0.15. Centene had a net margin of 1.12% and a return on equity of 11.82%. The firm had revenue of $37.19 billion during the quarter, compared to analysts’ expectations of $34.48 billion. During the same period in the prior year, the company earned $1.63 EPS. The firm’s revenue was up 24.0% on a year-over-year basis. Analysts forecast that Centene Co. will post 5.46 earnings per share for the current year.

CNC has been the topic of a number of analyst reports. Mizuho lifted their price objective on Centene from $78.00 to $84.00 and gave the company a “neutral” rating in a report on Wednesday, February 9th. Barclays initiated coverage on Centene in a report on Friday, January 7th. They issued an “overweight” rating and a $95.00 price objective on the stock. Truist Financial lifted their price objective on Centene from $94.00 to $96.00 and gave the company a “buy” rating in a report on Wednesday, January 5th. Deutsche Bank Aktiengesellschaft lifted their price objective on Centene from $84.00 to $88.00 and gave the company a “buy” rating in a report on Wednesday, February 9th. Finally, StockNews.com initiated coverage on Centene in a research note on Thursday, March 31st. They set a “strong-buy” rating on the stock. Four analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $91.61.

A number of large investors have recently bought and sold shares of the business. Glassman Wealth Services boosted its position in Centene by 19.5% in the 4th quarter. Glassman Wealth Services now owns 742 shares of the company’s stock valued at $61,000 after buying an additional 121 shares during the last quarter. Whittier Trust Co. boosted its position in Centene by 4.4% in the 1st quarter. Whittier Trust Co. now owns 2,981 shares of the company’s stock valued at $251,000 after buying an additional 125 shares during the last quarter. Harbor Investment Advisory LLC boosted its position in Centene by 3.6% in the 4th quarter. Harbor Investment Advisory LLC now owns 3,929 shares of the company’s stock valued at $324,000 after buying an additional 138 shares during the last quarter. AE Wealth Management LLC boosted its position in Centene by 3.3% in the 1st quarter. AE Wealth Management LLC now owns 4,748 shares of the company’s stock valued at $400,000 after buying an additional 150 shares during the last quarter. Finally, Atlas Capital Advisors LLC boosted its position in Centene by 3.5% in the 4th quarter. Atlas Capital Advisors LLC now owns 4,638 shares of the company’s stock valued at $382,000 after buying an additional 159 shares during the last quarter. 92.32% of the stock is owned by institutional investors.

Centene Company Profile (Get Rating)

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs.

Read More

Insider Buying and Selling by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.